Early Antiretroviral Therapy initiation: Access and Equity of Viral Load Testing for HIV Treatment Monitoring
Authors
Peter, TEllenberger, D
Kim, AA
Boeras, D
Messele, T
Roberts, T
Stevens, W
Jani, I
Abimiku, A
Ford, N
Katz, Z
Nkengasong, JN
Issue Date
2016-10-20Submitted date
2016-11-09
Metadata
Show full item recordJournal
The Lancet. Infectious DiseasesAbstract
Scaling up access to HIV viral load testing for individuals undergoing antiretroviral therapy in low-resource settings is a global health priority, as emphasised by research showing the benefits of suppressed viral load for the individual and the whole population. Historically, large-scale diagnostic test implementation has been slow and incomplete because of service delivery and other challenges. Building on lessons from the past, in this Personal View we propose a new framework to accelerate viral load scale-up and ensure equitable access to this essential test. The framework includes the following steps: (1) ensuring adequate financial investment in scaling up this test; (2) achieving pricing agreements and consolidating procurement to lower prices of the test; (3) strengthening functional tiered laboratory networks and systems to expand access to reliable, high-quality testing across countries; (4) strengthening national leadership, with prioritisation of laboratory services; and (5) demand creation and uptake of test results by clinicians, nurses, and patients, which will be vital in ensuring viral load tests are appropriately used to improve the quality of care. The use of dried blood spots to stabilise and ship samples from clinics to laboratories, and the use of point-of-care diagnostic tests, will also be important for ensuring access, especially in settings with reduced laboratory capacity. For countries that have just started to scale up viral load testing, lessons can be learnt from countries such as Botswana, Brazil, South Africa, and Thailand, which have already established viral load programmes. This framework might be useful for guiding the implementation of viral load with the aim of achieving the new global HIV 90-90-90 goals by 2020.Publisher
ElsevierPubMed ID
27773596Language
enISSN
1474-4457ae974a485f413a2113503eed53cd6c53
10.1016/S1473-3099(16)30212-2
Scopus Count
Collections
Related articles
- Dried blood spots can expand access to virological monitoring of HIV treatment in resource-limited settings.
- Authors: Johannessen A, Trøseid M, Calmy A
- Issue date: 2009 Dec
- Scaling up HIV viral load - lessons from the large-scale implementation of HIV early infant diagnosis and CD4 testing.
- Authors: Peter T, Zeh C, Katz Z, Elbireer A, Alemayehu B, Vojnov L, Costa A, Doi N, Jani I
- Issue date: 2017 Nov
- Field evaluation of dried blood spots for routine HIV-1 viral load and drug resistance monitoring in patients receiving antiretroviral therapy in Africa and Asia.
- Authors: Monleau M, Aghokeng AF, Eymard-Duvernay S, Dagnra A, Kania D, Ngo-Giang-Huong N, Touré-Kane C, Truong LX, Chaix ML, Delaporte E, Ayouba A, Peeters M, ANRS 12235 Study Group.
- Issue date: 2014 Feb
- Improving laboratory efficiencies to scale-up HIV viral load testing.
- Authors: Alemnji G, Onyebujoh P, Nkengasong JN
- Issue date: 2017 Mar
- Scale-up of Routine Viral Load Testing in Resource-Poor Settings: Current and Future Implementation Challenges.
- Authors: Roberts T, Cohn J, Bonner K, Hargreaves S
- Issue date: 2016 Apr 15